Brennan, A. M., Lee, J. H., Tsiodras, S., Chan, J. L., Doweiko, J., Chimienti, S. N., . . . Mantzoros, C. S. (2008). r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: Observational and interventional studies in humans.

Brennan, Aoife M., Jennifer H. Lee, Sotirios Tsiodras, Jean L. Chan, John Doweiko, Sonia N. Chimienti, Sanjivini G. Wadhwa, Adolf W. Karchmer, and Christos S. Mantzoros. R-metHuLeptin Improves Highly Active Antiretroviral Therapy-induced Lipoatrophy and the Metabolic Syndrome, but Not Through Altering Circulating IGF and IGF-binding Protein Levels: Observational and Interventional Studies in Humans. 2008.

Brennan, Aoife M., et al. R-metHuLeptin Improves Highly Active Antiretroviral Therapy-induced Lipoatrophy and the Metabolic Syndrome, but Not Through Altering Circulating IGF and IGF-binding Protein Levels: Observational and Interventional Studies in Humans. 2008.